new glp 1 drug GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness America's Poison Centers - GLP-1

Sources Consulted Secondary data for the market study was gathered from multiple credible sources, including: Government databases, regulatory bodies, and public institutions International organizations (WHO, OECD, IMF, World Bank, etc.) Commercial and paid databases Industry associations, trade publications, and technical journals Company annual reports, investor presentations, press releases, and SEC filings Academic research papers, patents, and scientific literature Previous market research publications and syndicated reports These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights

10 Similarly, another systematic review and meta-analysis of 764 randomised controlled trials also showed a reduction in all-cause mortality with use of GLP-1RAs (odds ratio [OR] 0.88

[published online June 21, 2025]

Diabetes Obes Metab 22:20892096

The median follow-up period for the entire cohort was 2.3 years

Furthermore, lifestyle choices and habits are integral to sustainable weight loss